Catalyst Event
Bristol-Myers Squibb Co (BMY) · Earnings Release
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
4/30/2026, 12:00:00 AM
Reported Q1 2026 revenue of $11.5 billion (+3% YoY) and non-GAAP EPS of $1.58, beating analyst estimates. The company reaffirmed its full-year 2026 guidance, with results trending toward the upper end of the range. The stock rose approximately 5% on the news.
Korean Translation
2026년 1분기 매출 115억 달러(전년 동기 대비 +3%), 비일반회계기준(Non-GAAP) 주당순이익(EPS) 1.58달러를 기록하여 시장 예상치를 상회함. 2026년 연간 가이던스를 재확인했으며, 실적이 가이던스 상단을 향해 가고 있다고 밝힘. 발표 후 주가는 약 5% 상승함.
Related Recent Events
Bristol-Myers Squibb Co (BMY) · Other
The U.S. Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) target action date of August 17, 2026, for its decision on iberdomide for relapsed or refractory multiple myeloma, scheduled. Low impact estimated as the target date is a procedural milestone.
8/17/2026, 12:00:00 AM
Blackstone Inc (BX) · Earnings Release
Blackstone is scheduled to release its Q2 2026 earnings results, with analysts forecasting earnings of approximately $1.34-$1.36 per share, scheduled.
7/23/2026, 12:00:00 AM
Union Pacific Corp (UNP) · Earnings Release
Q2 2026 earnings release is scheduled. Low impact estimated as the date announcement is a routine event; scheduled.
7/23/2026, 12:00:00 AM
Goldman Sachs Group Inc (The) (GS) · Earnings Release
Goldman Sachs' Q2 2026 earnings release is scheduled.
7/14/2026, 12:00:00 AM
NIKE Inc (NKE) · Earnings Release
Q4 Fiscal Year 2026 earnings release is scheduled for June 25, 2026. Low importance as the announcement of the date typically has a minimal market impact.
6/25/2026, 12:00:00 AM
Vistra Corp (VST) · Other
Quarterly dividend of $0.2290 per share with an ex-dividend date of June 22, 2026; low importance estimated as dividends usually cause minor price adjustments, scheduled.
6/22/2026, 12:00:00 AM